Építés alatt – nem éles oldal
Belépés
Befejeződött1/2. fázis

First-in-human phase I/IIa study investigating inhaled CIS-DPI as add-on treatment in Stage IV NSCLC patients

Key facts

Where
Brussels, Charleroi, Kortrijk, La Louvière, Liège, Mons és Roeselare, BelgiumSee the 7 sites
Phase
1/2. fázis

Where in Belgium

  • Institut Jules BordetBrussels, BelgiumNo longer taking part
  • Grand Hopital de CharleroiCharleroi, BelgiumNo longer taking part
  • Algemeen Ziekenhuis GroeningeKortrijk, BelgiumNo longer taking part
  • Chu HeloraLa Louvière, BelgiumNo longer taking part
  • CHU de LiègeLiège, BelgiumNo longer taking part
  • CHU Ambroise ParéMons, BelgiumNo longer taking part
  • AZ DeltaRoeselare, BelgiumNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Inhatarget Therapeutics
Trial code
EU 2022-501183-17-00
Record updated
2025. július 24.